Professor Riste?rd ? Laoide:

The cancer strategy was rolled out in 2017. It is a ten-year programme to 2026. We have received significant funding in the past two years for that, which is appreciated and has done a lot to advance the cancer strategy. We in the NCCP work closely with the Department of Health in empowering us to implement elements of the cancer strategy. Some of the things that will be important for us are the Sláintecare developments, the issue around governance and making changes to services. This is a programmatic model for cancer care in Ireland. We work across the whole pathway from prevention right through to survivorship and end-of-life care. The fact that Sláintecare and regional health authorities will be introduced will allow us to create a new governance structure within the health services to impact on how we deliver outcomes for our cancer services.